written on 20.06.2014
Tags:
,

Novartis in more hot water in Italy as officials probe possible pricing fraud

TAGS: ,

Novartis is already under scrutiny in Italy after authorities there accused it of colluding to protect sales of eye drug Lucentis. But the Swiss pharma's situation in the country may be getting stickier, with authorities scouring its offices there for information on flu vaccine pricing.

Latest Report